1964
DOI: 10.1126/science.145.3634.828
|View full text |Cite
|
Sign up to set email alerts
|

Release of Metaraminol (Aramine) from the Heart by Sympathetic Nerve Stimulation

Abstract: Cats were injected intravenously with metaraminol, an amine which depletes norepinephrine from the sympathetic nerve endings; their hearts were then perfused in vitro. Stimulation of the sympathetic nerve supply released metaraminol from the hearts, demonstrating that a synthetic compound can replace norepinephrine and serve as a transmitter at adrenergic nerve endings

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
27
0

Year Published

1965
1965
1999
1999

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 85 publications
(29 citation statements)
references
References 6 publications
2
27
0
Order By: Relevance
“…Consistent with this are the findings of Crout, Alpers, Tatum & Shore (1964), who have recently reported that sympathetic nerve stimulation can release metaraminol from the hearts of the animals previously treated with metaraminol. Their study and this one provide pharmacological evidence that metaraminol is bound in the nerve endings at sites ordinarily occupied by noradrenaline.…”
Section: Discussionsupporting
confidence: 84%
“…Consistent with this are the findings of Crout, Alpers, Tatum & Shore (1964), who have recently reported that sympathetic nerve stimulation can release metaraminol from the hearts of the animals previously treated with metaraminol. Their study and this one provide pharmacological evidence that metaraminol is bound in the nerve endings at sites ordinarily occupied by noradrenaline.…”
Section: Discussionsupporting
confidence: 84%
“…In the present investigation, an attempt was X Present Address: Medical Research Department, Hoffman-LaRoche & Co., Basel, Switzerland. made to characterize further these organ differences by comparing the release from brain and heart slices of metaraminol, a noradrenaline congener which acts as a non-metabolizable false transmitter at adrenergic nerve endings (Shore, Busfield & Alpers, 1964;Crout, Alpers, Tatum & Shore, 1964 30-60 mg) was used; with heart studies, a ventricle slice (0.3 mm, 60-80 mg) was used. Tissue slices were placed in 20 ml beakers containing 3 ml Krebs-Ringer bicarbonate buffer (pH 7.4) and bubbled with 95% 02 and 5% CO2 (Dengler, Michaelson, Spiegel & Titus, 1962 (Baldessarini & Kopin, 1967).…”
Section: Introductionmentioning
confidence: 99%
“…The metabolic fate of a-methyldopa and a-methyl-m-tyrosine being similar, the corresponding false neurotransmitters would be a-methylnoradrenaline (Muscholl & Maitre, 1963;Day & Rand, 1964) and metaraminol (Weissbach, 0. D. Gulati, H. M. Parikh, S. Y. Ringe and M. L. Sherlekar Lovenberg & Udenfriend, 1960;Lovenberg, Weissbach & Udenfriend, 1962;Crout & Shore, 1964) respectively. It has been demonstrated by Bejrablaya, Burn & Walker (1958), Burn & Rand (1958, 1960 and by numerous other investigators that dopa, dopamine and noradrenaline are able to restore the sympathomimetic action of tyramine in reserpine pretreated animals.…”
Section: Introductionmentioning
confidence: 99%